Client is a biopharmaceutical company that develops medicines in areas of unmet need.
Funding for HCV and public health activities via appropriations. Pharmaceutical policy as it relates to payments under the 340B program. Federal program coverage, access and reimbursement issues for Hepatitis C, HIV, and oncology products, including regulation "Modernizing Part D and Medicare Advantage to Lower Drug Prices and Reduce Out-of-Pocket Spending" (RIN 0938-AT92).
BUD - Budget/Appropriations HCR - Health Issues MMM - Medicare/Medicaid
2 - HOUSE OF REPRESENTATIVES 1 - SENATE 2 - HOUSE OF REPRESENTATIVES 1 - SENATE 2 - HOUSE OF REPRESENTATIVES 1 - SENATE
THE MCMANUS GROUP
610 10th St. NW, Suite 300, Washington, DC, 20001, US
BARRETT THORNHILL JOHN MCMANUS BARRETT THORNHILL JOHN MCMANUS BARRETT THORNHILL JOHN MCMANUS